Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes

Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes

HER2+ breast cancer (BC) is an aggressive subtype representing a genetically and biologically heterogeneous group of tumors resulting in variable prognosis and treatment response to HER2-targeted therapies according to estrogen (ER) and progesterone receptor (PR) expression. The relationship with an...

Full description

Bibliographic Details
Main Authors: Sandra Orrù, Emanuele Pascariello, Giovanni Sotgiu, Daniela Piras, Laura Saderi, Maria Rosaria Muroni, Ciriaco Carru, Caterina Arru, Cristina Mocci, Giampietro Pinna, Raffaele Barbara, Paolo Cossu-Rocca, Maria Rosaria De Miglio
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Biomedicines
Subjects:
HER2 expression
AR expression
breast cancer
prognosis
immunohistochemistry
Online Access:https://www.mdpi.com/2227-9059/10/1/164

Similar Items

Similar Items